Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,240 | -9,279 | -3,673 | 3,811 | -683 |
| Depreciation Amortization | 1,511 | 1,257 | 996 | 715 | 667 |
| Accounts receivable | -2,785 | -546 | 258 | 596 | 33 |
| Other Working Capital | -3,207 | -990 | 928 | -4,557 | 1,874 |
| Other Operating Activity | 4,928 | 2,765 | -3,318 | -8,449 | -4,656 |
| Operating Cash Flow | $-1,794 | $-6,793 | $-4,809 | $-7,884 | $-2,765 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -19 | -181 | -1,098 | -1,919 |
| Purchase Sale Intangibles | N/A | 350 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 350 | -94 | -7 | -30 |
| Investing Cash Flow | $-35 | $331 | $-275 | $-1,105 | $-1,949 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -220 | -210 |
| Common Stock Issued | 1,438 | 2,064 | 2,354 | 9,450 | 9,241 |
| Other Financing Activity | -749 | -497 | -682 | -1,158 | -269 |
| Financing Cash Flow | $690 | $1,567 | $1,671 | $8,071 | $8,762 |
| Beginning Cash Position | 2,676 | 7,571 | 10,984 | 11,512 | 7,464 |
| End Cash Position | 1,537 | 2,676 | 7,571 | 10,595 | 11,512 |
| Net Cash Flow | $-1,139 | $-4,895 | $-3,413 | $-918 | $4,048 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,794 | -6,793 | -4,809 | -7,884 | -2,765 |
| Capital Expenditure | -35 | -19 | -181 | -1,098 | -1,919 |
| Free Cash Flow | -1,829 | -6,812 | -4,990 | -8,982 | -4,684 |